{
  "id": 1768147811879,
  "seqId": 87,
  "title": "AMNIOTIC MEMBRANE TRANSPLANTATION & TISSUE BANKING",
  "summary": "A comprehensive guide to the histology, function, and application of Amniotic Membrane Transplantation (AMT), alongside the rigorous protocols for donor eye retrieval, screening, and eye bank storage standards.",
  "date": "2026-01-11T16:10:11.879Z",
  "data": {
    "title": "AMNIOTIC MEMBRANE TRANSPLANTATION & TISSUE BANKING",
    "summary": "A comprehensive guide to the histology, function, and application of Amniotic Membrane Transplantation (AMT), alongside the rigorous protocols for donor eye retrieval, screening, and eye bank storage standards.",
    "summary_illustration": "<svg viewBox=\"0 0 200 200\" xmlns=\"http://www.w3.org/2000/svg\"><circle cx=\"100\" cy=\"100\" r=\"80\" fill=\"none\" stroke=\"hsl(215, 90%, 45%)\" stroke-width=\"2\"/><path d=\"M40 100 Q100 20 160 100 Q100 180 40 100\" fill=\"none\" stroke=\"hsl(215, 90%, 45%)\" stroke-width=\"4\"/><circle cx=\"100\" cy=\"100\" r=\"25\" fill=\"hsl(215, 90%, 45%)\" fill-opacity=\"0.2\" stroke=\"hsl(215, 90%, 45%)\" stroke-width=\"2\"/><path d=\"M70 70 Q100 60 130 70\" fill=\"none\" stroke=\"hsl(215, 90%, 45%)\" stroke-width=\"2\" stroke-dasharray=\"4 2\"/></svg>",
    "sections": [
      {
        "title": "Amniotic Membrane: Histology & Composition",
        "icon": "microscope",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "purple",
        "content": {
          "center": "Amniotic Membrane (AM)",
          "branches": [
            "Origin: Part of the mammalian placenta (fetal amniochorion component)",
            "Histological Structure: Epithelial monolayer secreting a thick Basement Membrane (BM)",
            "Avascular Stroma Layer 1: Compact layer",
            "Avascular Stroma Layer 2: Fibroblast layer (contains resident macrophages; secretes compact layer components)",
            "Avascular Stroma Layer 3: Intermediate spongy layer (abundant in hydrated proteoglycans and glycoproteins)",
            "Surgical Preparation: Separated from chorion along the natural cleavage plane of the intermediate spongy layer"
          ]
        }
      },
      {
        "title": "Biological Functions & Properties",
        "icon": "science",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Primary action related to amnion matrix and BM substrate.",
          "Anti-inflammatory: Promotes inflammatory cell apoptosis.",
          "Antiangiogenic: Inhibits new vessel formation.",
          "Anti-scarring: Suppresses myofibroblast differentiation.",
          "Pathway Inhibition: Inhibits proteases and transforming growth factor (TgF)-β signalling.",
          "Bactericidal properties: Indicated by various studies.",
          "Immunological Benefit: Unlike most allografts, it does not result in immunological rejection.",
          "Note: Large biological inter- and intra-AM variation exists; synthetic alternatives are being sought."
        ]
      },
      {
        "title": "Applications of AM Transplantation (Table 7.18)",
        "icon": "assignment_turned_in",
        "type": "table",
        "layout": "half_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Category",
            "Indications"
          ],
          "rows": [
            [
              "Common",
              "Persistent corneal defects, Reconstruction of conjunctival defects, Chemical and thermal burns, Limbal stem cell deficiency, Bullous keratopathy, glaucoma surgery"
            ],
            [
              "Uncommon",
              "Band keratopathy, Post-refractive surgery haze, Corneal hydrops, Encasement of orbital prostheses, EOM surgery"
            ]
          ]
        }
      },
      {
        "title": "Modern Developments in Ocular AM",
        "icon": "biotech",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "blue",
        "content": [
          "Cryopreserved AM: Stored at −80°C in glycerol; sizes 2 × 2, 3 × 3, 5 × 5cm (NHSBT and Tissue Services). Requires thawing prior to use.",
          "Tereo™: Dry-preservation (Nu-Vision Omnigen™). Available in a range of sizes and shapes. In vivo rehydration.",
          "ProKera™ device: Cryopreserved AM stretched across a PMMA skirt. Versions: classic, xL, Slim (Bio-Tissue).",
          "OmniLenz™ device: Dry-preserved AM mounted on the posterior aspect of the contact lens (Nu-Vision)."
        ]
      },
      {
        "title": "Donor Eye Retrieval & Eye Banks",
        "icon": "account_balance",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "blue",
        "content": "Corneal transplantation depends on the availability of screened deceased donor corneo-scleral tissue, preserved in optimal conditions by a dedicated eye bank. In the UK, the majority of corneas are stored by the Corneal Transplantation Service Eye Banks in Bristol and Manchester. Retrieval should be carried out by somebody competent in enucleation or trained in eye retrieval (usually ophthalmic nurses, technicians, or doctors). A local transplant coordinator usually discusses consent and suitability, but the person performing retrieval must verify both."
      },
      {
        "title": "Consent & Screening Protocols",
        "icon": "fact_check",
        "type": "process",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "1. Obtain consent from the most relevant life partner or closest family member.",
          "2. Confirm donor agreement/no objection and permission for research use if unsuitable for transplant.",
          "3. Obtain consent for blood tests (infective risk) and access to medical records.",
          "4. Screen for infective agents or malignancy via records, staff, family, 1° healthcare practitioners, and post-mortem.",
          "5. Perform mandatory serological tests for infective agents."
        ]
      },
      {
        "title": "Surgical Procedure: Enucleation & Processing",
        "icon": "content_cut",
        "type": "process",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "1. Use aseptic technique and disinfection (e.g., povidone iodine 10%).",
          "2. Perform peritomy to isolate and sever EOM with squint hook/strabismus scissors.",
          "3. Slide closed enucleation scissors around the eye to sever the optic nerve.",
          "4. Remove globe, pack sockets with cotton wool, and close lids over plastic eye caps.",
          "5. Clean donor eyes (povidone iodine 10%) and excise corneoscleral disc in a Class II biological safety cabinet.",
          "6. Follow Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) codes."
        ]
      },
      {
        "title": "Storage & Issuing Protocols",
        "icon": "thermostat",
        "type": "table",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": {
          "headers": [
            "Tissue/Method",
            "Conditions",
            "Duration & Notes"
          ],
          "rows": [
            [
              "Corneoscleral (Organ Culture)",
              "Suspension medium at 34°C",
              "Store for 30d. Adv: Long storage; screen risk by sampling medium at 7d."
            ],
            [
              "Corneoscleral (Hypothermic)",
              "Storage at 4°C",
              "Store for 7–10d. Adv: Simple. Disadv: Shorter time; risk identification harder."
            ],
            [
              "Sclera",
              "70% ethanol",
              "Stored for up to 1y."
            ],
            [
              "Whole Eyes (Short-term)",
              "Moist chamber, cornea uppermost, 4°C/ice",
              "Humidity via moistened cotton wool in closed pot during transit."
            ]
          ]
        }
      },
      {
        "title": "The 3-Day Issuing Countdown",
        "icon": "event",
        "type": "process",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "T-minus 3 Days: Examine corneal endothelium. Cell count must be ≥2,200 cells/mm2. Return to 34°C.",
          "T-minus 2 Days: Sample medium again to assess for infection.",
          "T-minus 1 Day: Send corneas in medium at ambient temperature to the operating hospital."
        ]
      },
      {
        "title": "Infection Contraindications (Table 7.19)",
        "icon": "dangerous",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Known: HIV, viral hepatitis (A, B, or C), HTLV, viral/unknown encephalitis, viral meningitis, rabies, congenital rubella, TB.",
          "Known: Reyes syndrome, progressive multifocal leukoencephalopathy, septicaemia.",
          "Seropositivity: HIV (1 or 2), HBsAg, HCV, HTLV, syphilis.",
          "Risk Behaviors: Behavioral risk for HIV/Hepatitis/HTLV, Imprisonment <12mo, Tattoos/piercing/acupuncture <4mo before death.",
          "Medical: Bleeding disorders treated with blood-derived coagulation concentrates."
        ]
      },
      {
        "title": "Other Contraindications (Table 7.19)",
        "icon": "cancel",
        "type": "red_flag",
        "layout": "full_width",
        "color_theme": "red",
        "content": [
          "Previous Surgery/Receipt: Immunosuppression, organ transplant (corneal, scleral, or limbal), human pituitary-derived hormones.",
          "Neurological: Receipt of dura or brain/spinal surgery pre-August 1992; Creutzfeld–Jakob disease, dementias, MS, Parkinson's; Death from unknown cause.",
          "Malignant/Premalignant: Leukaemia, lymphoma, myeloma, sideroblastic anaemia, polycythemia, myeloblastic syndrome.",
          "Ocular Conditions: Active ocular inflammation/uveitis, retinoblastoma, malignant tumours of the anterior segment.",
          "Graft Failure Risk: Any congenital or acquired disorders (including previous refractive surgery) that preclude successful outcome."
        ]
      },
      {
        "title": "Standards Source",
        "icon": "menu_book",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "purple",
        "content": "As outlined in Annex 1 of the Royal College of Ophthalmologists Standards for the retrieval of human ocular tissue used in transplantation, research and training, 2013."
      }
    ]
  },
  "chapterId": "cornea",
  "_serverSynced": true
}